IBRX
USDImmunityBio Inc. Common Stock
$2.720-0.175 (-6.045%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.895
High
$3.000
Low
$2.700
Volume
3.28M
Company Fundamentals
Market Cap
2.4B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
9.22M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.83Current $2.720High $7.48
Related News
Analyst Upgrades
D. Boral Capital Maintains Buy on ImmunityBio, Maintains $30 Price Target
D. Boral Capital analyst Jason Kolbert maintains ImmunityBio with a Buy and maintains $30 price target.
View more
BusinessWire
UK MHRA Approves ImmunityBio's ANKTIVA® Plus BCG for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma In Situ
ANKTIVA, a first-in-class, lymphocyte-stimulating agent, works synergistically with BCG to activate and proliferate natural killer (NK) and T cells, helping eliminate cancer Already approved in the U.S. and
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.